Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of the drug lixisenatide on blood sugar
levels, stomach emptying, blood pressure and heart rate, release of gut hormones and blood
flow in the gut after a glucose drink in both healthy subjects and people with type 2
diabetes. If lixisenatide is shown to be effective, it would encourage ongoing evaluation of
its potential use in the management of the falls in blood pressure following a meal in
diabetic patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Royal Adelaide Hospital
Collaborators:
National Health and Medical Research Council, Australia Sanofi